Literature DB >> 14535996

Interactions between inducible nitric oxide and other inflammatory mediators during Helicobacter pylori infection.

Marygorret Obonyo1, Donald G Guiney, Joshua Fierer, Sheri P Cole.   

Abstract

BACKGROUND: Recent studies in both humans and animal models strongly suggest the contribution of the host immune response to Helicobacter pylori-related disease. Inducible nitric oxide synthase has been shown to be up-regulated in the gastric epithelium during H. pylori gastritis, suggesting a role in inflammation.
MATERIALS AND METHODS: C57BL/6 wild-type and inducible nitric oxide synthase gene knockout mice were infected with H. pylori strain SS1. Expression of macrophage inflammatory protein-2 (MIP-2), interleukin-1 beta (IL-1 beta), Th1 (IL-2 and gamma interferon) and Th2 (IL-4 and IL-10) cytokines, and inducible cyclooxygenase mRNA in mice was determined in mouse gastric tissues and quantified using either competitive reverse transcription-polymerase chain reaction or competitive polymerase chain reaction following reverse transcription.
RESULTS: The Th1 cytokine gamma interferon was only detected in wild-type and inducible nitric oxide synthase gene knockout infected mice, while a Th2 (IL-4) response was not detected. H. pylori induced MIP-2 and IL-1 beta mRNA in mice.
CONCLUSIONS: Because similar levels of inflammatory mediators were noted in both wild-type and nitric oxide synthase gene knockout infected mice, our data suggest that inducible nitric oxide synthase does not influence expression of these inflammatory mediators in the early stages of H. pylori infection in mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14535996     DOI: 10.1046/j.1523-5378.2003.00171.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  8 in total

Review 1.  The Immune Battle against Helicobacter pylori Infection: NO Offense.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Trends Microbiol       Date:  2016-02-22       Impact factor: 17.079

2.  Effects of myeloid differentiation primary response gene 88 (MyD88) activation on Helicobacter infection in vivo and induction of a Th17 response.

Authors:  Marygorret Obonyo; Barry Rickman; Donald G Guiney
Journal:  Helicobacter       Date:  2011-10       Impact factor: 5.753

3.  Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.

Authors:  Dionyssios N Sgouras; Effrosini G Panayotopoulou; Beatriz Martinez-Gonzalez; Kalliopi Petraki; Spyros Michopoulos; Andreas Mentis
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

4.  Gastric helicobacter infection induces a Th2 phenotype but does not elevate serum cholesterol in mice lacking inducible nitric oxide synthase.

Authors:  Melanie Ihrig; Mark T Whary; Charles A Dangler; James G Fox
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori.

Authors:  Marygorret Obonyo; Mojgan Sabet; Sheri P Cole; Joerg Ebmeyer; Satoshi Uematsu; Shizuo Akira; Donald G Guiney
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

Review 6.  Human and Helicobacter pylori Interactions Determine the Outcome of Gastric Diseases.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

7.  Helicobacter pylori chemotaxis modulates inflammation and bacterium-gastric epithelium interactions in infected mice.

Authors:  Susan M Williams; Yu-Ting Chen; Tessa M Andermann; J Elliot Carter; David J McGee; Karen M Ottemann
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

8.  The homing receptor CD44 is involved in the progression of precancerous gastric lesions in patients infected with Helicobacter pylori and in development of mucous metaplasia in mice.

Authors:  Jone Garay; M Blanca Piazuelo; Sumana Majumdar; Li Li; Jimena Trillo-Tinoco; Luis Del Valle; Barbara G Schneider; Alberto G Delgado; Keith T Wilson; Pelayo Correa; Jovanny Zabaleta
Journal:  Cancer Lett       Date:  2015-11-27       Impact factor: 8.679

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.